Clinical Trial Update: A Comparison of Three Different Formulations of Prednisolone Acetate 1% [Phase 4]

View source ↗

Summary

A Phase 4 study compared three different formulations of prednisolone acetate 1% eye drops in patients with glaucoma or cataract. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma

Drugs mentioned

• Prednisolone Acetate 1% (prednisolone acetate)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Glaucoma, Cataract | Phase 4 | Status: COMPLETED | Results posted: 2014-04-21